Manhattan Scientifics, Inc. Signs LOI to Acquire Rights to Early Cancer Detection System Developed by Dr. Edward R. Flynn
10/20/2009 9:57:04 AM
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTCBB: MHTX) announced today that it has entered into a non-binding letter of intent (LOI) with Edward R. Flynn, Ph.D. and his company, Senior Scientific, LLC, to acquire all the manufacturing and marketing rights, together with all commercial rights associated with Dr. Flynn’s patents and IP in the emerging field of nanomedicine. Dr. Flynn’s work is focused on the biomagnetic detection of cancer and other diseases through magnetic field sensors with enhanced accuracy.
comments powered by